September 13, 2008 |
A new way to test for cervical cancer is more accurate than a pap smear and identifies more dangerous lesions, according to an Italian study published Tuesday. Researchers used the traditional test for the human papilloma virus that causes cervical cancer and combined it with another that indicated specific cancer-causing activity in cells. The test looked for a protein called P16INK4A, which indicates cell changes that show a woman probably has precancerous lesions, the team reported in the journal Lancet Oncology.
August 18, 2008
The article [“Gardasil Vaccine Doubts Grow,” Aug. 11] is irresponsible and grossly misleading. It will scare parents away from potentially lifesaving protection against cervical cancer (and genital warts) for their daughters. Of course "some doctors and parents" have concerns -- it would be impossible to get unanimity on any medical topic. But all pediatric and vaccine experts, as well as all federal health officials, advocate vaccination of preteen and young teen girls against human papilloma virus.
August 11, 2008 |
Sandra Levy wants to do everything she can to safeguard the health of her 11-year-old daughter -- and that, of course, includes cancer prevention. She has had her child inoculated with one shot of Gardasil, the human papilloma virus vaccine that may prevent cervical cancer. But now, she says, she has serious reservations about going ahead with the next two injections of the course. "It's very confusing, and we really don't know if it's 100% safe," says Levy, of Long Beach.
March 12, 2008 |
About 1 in 4 teenage girls in the United States -- and nearly half of black girls -- has at least one sexually transmitted disease, according to a new study. Those numbers translate into an estimated 3.2 million adolescent females infected with one of the four most common STDs -- many of whom may not even know they have a disease or that they are passing it to their sex partners. "What we found is alarming," said Dr. Sara Forhan, a researcher with the Centers for Disease Control and Prevention in Atlanta and the study's lead author.
January 28, 2008 |
Vaccines aren't just for kids, but far too few grown-ups are rolling up their sleeves, disappointed federal health officials reported Wednesday. The numbers of the newly vaccinated are surprisingly low, considering how much public attention a trio of new shots -- which protect against shingles, whooping cough and cervical cancer -- have received. Yet many people seem to have missed, or forgotten, the news: A survey by the National Foundation for Infectious Diseases found that aside from the flu, most adults have trouble naming diseases that they could prevent with a simple inoculation.
November 9, 2007 |
Women who take the birth control pill for 10 years have nearly double the normal risk of developing cervical cancer, but the risk begins falling as soon as they stop and returns to near normal within 10 years, according to a study released Thursday. The study confirms previous research linking the pill with an increased risk of cervical cancer and reveals for the first time that the risk falls after pill use stops, said Dr.
October 18, 2007 |
Using a traditional Pap smear with a relatively new screening test for the virus that causes cervical cancer significantly improves the chances of early detection, according to new research published today. The study of 12,527 women found that the combination of tests detected 51% more cancers and precancerous lesions in initial screenings than the Pap test alone.
July 2, 2007 |
Advertisements can be very persuasive -- whether they're promoting a snack food, a toy or even a medical test. If you've watched much television lately, you may have seen a commercial touting the benefits of a relatively new screening test for cervical cancer. Its message is unambiguous: "A Pap test isn't enough." The advertisement encourages women to get tested for human papillomavirus (HPV), the virus known to cause cervical cancer.
May 29, 2007
WHEN LOBBYISTS for major drug companies embark on major pushes with politicians, the results are seldom laudable. Though there is reason to hope that a new Merck vaccine, Gardasil, will significantly reduce the incidence of cervical cancer, lawmakers nationwide moved with unseemly haste to require inoculations for all young girls. Their rush seems especially precipitous in light of a new study that has raised questions about how effective the vaccine ultimately will prove.
May 10, 2007 |
New data on the controversial HPV vaccine designed to prevent cervical cancer have raised serious questions about its efficacy, researchers reported today, potentially undercutting the efforts in many states to make vaccination mandatory. Although the vaccine, called Gardasil, blocked about 100% of infections by the two human papilloma virus strains it targets, it reduced the incidence of cancer precursors by only 17% overall.